Michael Zand – Page 416

Voyager’s Gene Therapy Improves Parkinson’s Patients’ Movement Over Long Term, Trial Shows – Parkinson’s News Today

2018-03-12 Michael Zand NEWS

CAR T-cell therapy holds promise for multiple myeloma – Healio

CAR T-cell therapy holds promise for multiple myelomaHealioNEW YORK — Cellular immunotherapies such as chimeric antigen receptor therapy are a promising approach for treatment of multiple myeloma, according to a presenter at HemOnc Today New York. CAR … Continue reading

2018-03-12 Michael Zand NEWS

Synlogic Presents Clinical and Preclinical Data from Synthetic Biotic™ Medicine Programs for Treatment of Inborn … – Business Wire (press release)

Business Wire (press release)Synlogic Presents Clinical and Preclinical Data from Synthetic Biotic™ Medicine Programs for Treatment of Inborn …Business Wire (press release)CAMBRIDGE, Mass.–(BUSINESS WIRE)–Synlogic (Nasdaq:SYBX), a clinical-stage co… Continue reading

2018-03-12 Michael Zand NEWS

Analyzing Beyondspring (BYSI) & Editas Medicine (EDIT) – The Lincolnian Online

Analyzing Beyondspring (BYSI) & Editas Medicine (EDIT)The Lincolnian OnlineIt is developing a genome editing platform based on clustered, regularly interspaced short palindromic repeats (CRISPR) technology. CRISPR uses a protein-ribonucleic acid (… Continue reading

2018-03-12 Michael Zand NEWS

Beyondspring (BYSI) & Editas Medicine (EDIT) Head to Head Survey – Week Herald

Beyondspring (BYSI) & Editas Medicine (EDIT) Head to Head SurveyWeek HeraldIt is developing a genome editing platform based on clustered, regularly interspaced short palindromic repeats (CRISPR) technology. CRISPR uses a protein-ribonucleic acid (… Continue reading

2018-03-12 Michael Zand NEWS

Slow-release hydrogel aids immunotherapy for cancer – European Pharmaceutical Review

European Pharmaceutical ReviewSlow-release hydrogel aids immunotherapy for cancerEuropean Pharmaceutical ReviewAn immunotherapy drug embedded in a slow-release hydrogel appears to be highly effective at killing cancer cells. STINGel combines a new clas… Continue reading

2018-03-12 Michael Zand NEWS

1
…
414
415
416
417
418
…
3,823

Parkinson’s News Today

Voyager’s Gene Therapy Improves Parkinson’s Patients’ Movement Over Long Term, Trial Shows
Parkinson’s News Today
A single administration of Voyager Therapeutics gene therapy improves advanced Parkinson’s patients’ movement up to three years later, a Phase 1b trial indicates. Voyager designed VY-AADC01 to deliver the aromatic L-amino acid decarboxylase (AADC) gene …

Login

Cart

All posts by: Michael Zand

OncoSec Announces Publication In Nature Gene Therapy Demonstrating Efficacy Of IL-12 Intratumoral Gene … – PR Newswire (press release)

Immune Design (IMDZ) Announces Data Update for Lead Immunotherapy Programs – StreetInsider.com

Voyager’s Gene Therapy Improves Parkinson’s Patients’ Movement Over Long Term, Trial Shows – Parkinson’s News Today

CAR T-cell therapy holds promise for multiple myeloma – Healio

Synlogic Presents Clinical and Preclinical Data from Synthetic Biotic™ Medicine Programs for Treatment of Inborn … – Business Wire (press release)

Analyzing Beyondspring (BYSI) & Editas Medicine (EDIT) – The Lincolnian Online

Beyondspring (BYSI) & Editas Medicine (EDIT) Head to Head Survey – Week Herald

Slow-release hydrogel aids immunotherapy for cancer – European Pharmaceutical Review